Venture Certified
| 벤처투자유형 | 2017-12-21 ~ 2019-12-20 | 20170300731 | 2017-12-21 |
| 벤처투자유형 | 2019-12-21 ~ 2021-12-20 | 20190301147 | 2017-12-21 |
| 벤처투자유형 | 2023-06-28 ~ 2026-06-27 | 20230628010009 | 2017-12-21 |
Revenue CAGR +26.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 8.3B | -3.9B | 5.2B |
| Operating Profit | -8.4B | -42.2B | -48.4B |
| Net Profit | -4.3B | -40.2B | -47.7B |
| Total Assets | 18.6B | 20.6B | 31.7B |
| Total Liabilities | 24.4B | 22.1B | 9.8B |
| Total Equity | -5.9B | -1.5B | 21.8B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -8B
3 Consecutive Years of Net Loss
▲ 1191.1%
▲ 81.4%
▼ 236.2%
▲ 40.2%
▼ 93.8%
| Name | Position | Role |
|---|---|---|
| 서정법 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 성남시",
"ceo_name": "서정법",
"certificate": [
{
"cert_number": "20170300731",
"changes": "",
"disclosure_date": "2017-12-21",
"first_cert_date": "2017-12-21",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2017-12-21 ~ 2019-12-20"
},
{
"cert_number": "20190301147",
"changes": "",
"disclosure_date": "2019-12-11",
"first_cert_date": "2017-12-21",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2019-12-21 ~ 2021-12-20"
},
{
"cert_number": "20230628010009",
"changes": "",
"disclosure_date": "2023-06-28",
"first_cert_date": "2017-12-21",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2023-06-28 ~ 2026-06-27"
}
],
"company_name": "(주)비씨켐",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 1131753000,
"cost_of_sales": 0,
"current_assets": 719788000,
"current_liabilities": 409135000,
"gross_profit": 519525000,
"net_income": -4771302000,
"net_income_bs": -4771302000,
"non_current_assets": 2448227000,
"non_current_liabilities": 573968000,
"non_operating_expenses": 1617000,
"non_operating_income": 70129000,
"operating_profit": -4839814000,
"revenue": 519525000,
"sga_expenses": 5359339000,
"total_assets": 3168015000,
"total_equity": 2184912000,
"total_liabilities": 983103000
},
"2023": {
"capital_stock": 1215746000,
"cost_of_sales": 0,
"current_assets": 39163000,
"current_liabilities": 1634443000,
"gross_profit": -390916000,
"net_income": -4018886000,
"net_income_bs": -4018886000,
"non_current_assets": 2019005000,
"non_current_liabilities": 577848000,
"non_operating_expenses": 18855000,
"non_operating_income": 224901000,
"operating_profit": -4224932000,
"revenue": -390916000,
"sga_expenses": 3834016000,
"total_assets": 2058168000,
"total_equity": -154123000,
"total_liabilities": 2212291000
},
"2024": {
"capital_stock": 1215745000,
"cost_of_sales": 0,
"current_assets": 76401000,
"current_liabilities": 2214140000,
"gross_profit": 830213000,
"net_income": -434326000,
"net_income_bs": -434326000,
"non_current_assets": 1779889000,
"non_current_liabilities": 230600000,
"non_operating_expenses": 26827000,
"non_operating_income": 436162000,
"operating_profit": -843661000,
"revenue": 830213000,
"sga_expenses": 1673874000,
"total_assets": 1856290000,
"total_equity": -588450000,
"total_liabilities": 2444740000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "300,000,000",
"changes": "300,000,000",
"date": "2020-10-23"
},
{
"amount": "1,128,556,000",
"changes": "1,128,556,000",
"date": "2020-10-23"
},
{
"amount": "999,986,000",
"changes": "999,986,000",
"date": "2019-04-11"
},
{
"amount": "480,000,000",
"changes": "480,000,000",
"date": "2019-02-15"
}
],
"main_products": "항암제, 치매치료제, 파킨스병 치료제 연구개발",
"phone": "031-698-****",
"years": [
2024,
2023,
2022
]
}